Nilörn

Nilörn

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Nilörn - Headwinds could subside in H2'26

13 februari 2026

  • A soft end to '25 on earnings
  • We cut '26e-'27e adj. EBIT by 7-6%
  • Trading at ~7x EV/EBIT on our NTM estimates

Q4: strong orders but pressured margins

Q4 was a weak quarter on adj. EBIT, ~30% below expectations despite a 2% beat on sales and a gross margin of 47.2% vs 46.2% in Q4'24. FX had an impact on Q4 sales of SEK -27m, and we believe that FX headwinds contributed to the net-negative effect on earnings. The adj. EBIT margin amounted to 5.2%, the lowest level since Q4'23. Management alluded that the margin pressure was due to FX, negative scale on operating leverage and elevated administrative expenses. Order bookings increased by 5.5% y-o-y to SEK 251m, which was above our expectations, and was partly driven by a large order of SEK 18m that spilled over from Q3 due to a later seasonal pattern in 2025.

We cut estimates on FX and increased opex

We leave our '26e-'27e organic sales estimates largely unchanged, but updated FX movements lead to sales estimate cuts of ~3% p.a. for '26e-'27e. Moreover, we cut '25e-'27e adj. EBIT by 7-6% on the back of the report. We keep our assumptions that the '26e-'27e GM will be slightly lower than in '25e, as packaging sales should return once the luxury market recovers (management expects this to happen by mid-2026). We believe that Nilörn's profitability will gradually increase as the current investments in e.g. the new Bangladesh factory start to pay off. Our estimates imply an 11% adj. EBIT margin in '28e.

Valuation

Our updated estimates imply that Nilörn is trading at an NTM EV/EBIT of ~7x, which is ~17% below the five-year median for Nilörn and ~25% below peers.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-03-12 StrongPoint - Investor update StrongPoint Analys
2026-03-08 Medicover - From build-out to fill-up Medicover Analys
2026-03-02 Qben Infra - Portfolio reshaping continues Qben Infra Analys
2026-02-27 Xplora Technologies - Record quarter driven by Se... Xplora Tech.. Analys
2026-02-24 Isofol Medical - From first lessons to second exe... Isofol Medical Analys
2026-02-24 B3 Consulting Group - Cost adjustments should lif... B3 Consulti.. Analys
2026-02-23 Ework Group - Market conditions yet to improve Ework Group Analys
2026-02-23 Formpipe - Good margins, but ACV lags Formpipe Analys
2026-02-23 Energy Save - Back to growth, but softer H1'26 ex... Energy Save Analys
2026-02-23 Fastpartner - Outlook taking a hit Fastpartner Analys
2026-02-23 Cavotec - Industry shines in cautious environment Cavotec Analys
2026-02-20 Arctic Paper - Still challenging Arctic Paper Analys
2026-02-20 Inission - Set for substantial earnings growth Inission Analys
2026-02-20 BTS Group - Ahead of plan on growth recovery BTS Group Analys
2026-02-20 Energy Save - OEM sales up, softer start to '26 e... Energy Save Analys
2026-02-20 Formpipe - Weaker ACV, but higher dividends Formpipe Analys
2026-02-20 B3 Consulting Group - Margin beat on cost cuts B3 Consulti.. Analys
2026-02-20 BTS Group - North America behind Q4 miss BTS Group Analys
2026-02-20 Skolon - Q4'25 momentum to also pay off in H1'26 Skolon Analys
2026-02-20 Ogunsen - Easier comps await in '26e Ogunsen Analys